Biotech Onward Therapeutics Announces IMPD Approval for Its Subsidiary Emercell to Start Clinical Investigation of Allogeneic NK Cell Therapy OT-C001 in Combination with Rituximab April 22, 2025
Biotech DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies April 21, 2025
Biotech YB-800 ADCs Reach Important Milestone: Proof of Concept in Preclinical in Vitro and in Vivo Tests April 20, 2025
Biotech Akeso’s Ebdarokimab ( IL – 12/IL – 23 Dual – Targeted Monoclonal Antibody) Approved in China for Moderate – to – Severe Plaque Psoriasis April 19, 2025
Biotech VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model April 18, 2025
Biotech Henlius 2025 Global R&D Day: Harnessing the Power of Innovation to Propel Global Strategy to New Heights April 17, 2025
Biotech Wayfinder Biosciences and Daiichi Sankyo collaborate to develop novel RNA-targeting therapies for neurodegenerative disease April 16, 2025
Biotech Fangzhou Presents AI-Driven Healthcare Ecosystem at Guangzhou Biotech Innovation Salon April 14, 2025
Biotech Innovative Startups Developing Next-Gen Cancer Treatments and Radiation-Shielding Material Selected Through MassChallenge Accelerator for Space-Based Research April 13, 2025
Search
Biotech
April 22, 2025
April 21, 2025
April 20, 2025
April 19, 2025
April 18, 2025
April 17, 2025
April 16, 2025
April 15, 2025
April 14, 2025
April 13, 2025
